Menlo Therapeutics marching ahead with its Phase 2 clinical trial in Pruritis
Menlo Therapeutics (NASDAQ: MNLO), a late-stage biopharmaceutical company, has announced the completion of enrollment of patients in a crucial phase 2 clinical trial...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
5 Prominent Companies in the Cannabis Consulting Market
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by...
Blink Charging – Charging Ahead with its first EV Charging Unit in Greece
Blink Charging (NASDAQ: BLNK), a provider of Electric Vehicle (EV) charging equipment, announced its foray into Greece, with the deployment of its first Blink electric...
Sweet Tidings as vTv Therapeutics announces additional positive data from its Type 1 diabetes clinical trial
vTv Therapeutics (NASDAQ: VTVT), a clinical stage biotechnology company, presented additional positive data from a phase 2 Simplici-T1 study in patients with type...
Will the E-Cigarette Dream Run Evaporate in Smoke?
The Food and Drug Administration of America (FDA) has initiated a criminal investigation into the supply chain of Cannabis, to tackle the vaping...
Wrap Technologies – Burgeoning demand for BolaWrap provides impetus to the Company’s Growth Plans
Wrap Technologies (NASDAQ: WRTC), a pioneer in novel policing solutions, announced the filing of nearly 45 initial orders for BolaWrap devices and accompanying...
Alkaline Water Company to test new waters with acquisition of Aquahydrate
The Alkaline Water Company (NASDAQ:WTER) today announced the signing of a landmark deal with potential to transform its brand name and portfolio. The...
Aytu BioScience to acquire Innovus Pharmaceuticals
Aytu BioScience (NASDAQ: AYTU), a specialty pharmaceutical Company engaged in developing solutions for unmet needs in areas such as virility, reproductive health, severe...
Emerging Paradigms in the treatment of NASH (Non-Alcoholic Steatohepatitis)
Nonalcoholic Steatohepatitis (NASH) is a form of Non-Alcoholic Fatty Liver Disease (NAFLD) and is characterized by the buildup of FAT in the liver....
